Home › Ligand Pharmaceutica PT Raised to $26.00 at Cantor Fitzgerald
 

Keywords :   


Ligand Pharmaceutica PT Raised to $26.00 at Cantor Fitzgerald

2013-03-23 21:53:55| Biotech - Topix.net

The firm currently has a "hold" rating on the stock. The analysts wrote, "On March 14 the company announced its license and global supply agreement with Spectrum Pharmaceuticals on Captisol-enabled Melphalan for the treatment of multiple myeloma.

Tags: raised fitzgerald cantor ligand

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
28.09Tropical Storm Joyce Forecast Advisory Number 5
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 11
More »